Ginseng has been commonly used in Oriental medicine to treat diabetes-like
conditions, and the earliest recorded reference for this purpose is in the
Compendium of Materia Medica (Ben Cao Gang Mu) by Dr Li in Ming Dynasty China
(1368-1644). This is the most complete and comprehensive pre-modern herbal
textbook. It is also recommended and used in North America for this purpose.
There is a large body of scientific evidence on the beneficial effect of
American ginseng for use in the management of diabetes and enhanced energy
metabolism in the body in non-diabetic people. Much of this is from randomized
placebo-controlled trials in people. There are numerous published scientific
studies on American ginseng's mode of action in normalizing blood glucose.
Although not fully understood, it appears to act in two ways. Firstly by
improving sensitivity to insulin due to a sulfonylurea-like activity. Secondly,
American ginseng has been found to increase the production of insulin by
pancreatic B cells, and also reduce apoptosis (programmed cell death) in these
cells.
Research in the USA demonstrates that American ginseng root powder significantly
(p < 0.05) reduces post-prandial glucose in people with Type-2 diabetes, and
also improves glucose tolerance in non-diabetic people. The dose generally used
was 1 to 3 grams, and increasing this dose did not appear to confer addition
benefit.
A 2003 review published in the US journal Diabetes Care examined all available
clinical studies on herbal, vitamin and mineral supplements claimed to influence
glycaemic control (that were published in English).108 trials were examined, and
the quality of randomised placebo-controlled trials was assessed using the Jadad
scale. The review concluded that the best evidence for efficacy from adequately
designed randomised trials is available for Coccinia and Panax quinuefolius
(American ginseng).
In the Journal American College of Nutrition (2003), Sievenpiper reported that
American ginseng was more effective than Korean ginseng in lowering blood
glucose. He speculated that differences in the levels of certain ginsenosides
between the two species were responsible for their differing actions.
Korean and US research published in Jan 2006 demonstrated that PPT ginsenosides
(particularly Rf) increase the activity of key receptors that regulate lipid and
glucose metabolism and fat differentiation. The authors concluded that these
ginsenosides can improve insulin resistance associated with diabetes.
Chinese research (2003) has found that both American and Korean ginseng saponins
inhibited the activity of pancreatic lipase by 90% and 35.2% respectively. Rc,
Rb1 & Rb2 inhibited pancreatic lipase by 100, 96 and 97% respectively. They
concluded that these results indicate the potential use of these saponins to
treat obesity.
Please note:
Any scientific information has been assembled by Simply Ginseng from
reputable peer-reviewed scientific journals. We have tried to ensure it is
clear, balanced and without bias. This information should not be construed
as claims for any of our products. Always consult your health care
professional.Use only as directed. Always read the label.